NCT00631306|Completed
Loading search results
Sponsor study identifier
observational
60
1 country
1
Study Start
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2009
Actual (reported)Study Completion
December 2010
Actual (reported)This study is being done to determine if the use of double strength cranberry juice in daily diet will improve endothelial function.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2010
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
February 28, 2008
Actual (reported)March 7, 2008
Actual (reported)December 2009
Actual (reported)December 2010
Actual (reported)The current study was designed to test the hypothesis that the chronic administration of supplementation with double-strength cranberry juice will improve peripheral endothelial dysfunction.
baseline and 4 months post
The current study was also designed to test the acute effect of double-strength cranberry juice on endothelial function.
45 mins post consumption
Patients are randomized to either Bottle number 615 or Bottle number 429 (actual product vs. placebo). This is a blinded study.
Patients are randomized to either Bottle number 615 or Bottle number 429 (actual product vs. placebo). This is a blinded study.
Mayo Clinic Patients
Mayo Clinic
Rochester, Minnesota, 55905, United States
Flammer AJ, Martin EA, Gossl M, Widmer RJ, Lennon RJ, Sexton JA, Loeffler D, Khosla S, Lerman LO, Lerman A. Polyphenol-rich cranberry juice has a neutral effect on endothelial function but decreases the fraction of osteocalcin-expressing endothelial progenitor cells. Eur J Nutr. 2013 Feb;52(1):289-96. doi: 10.1007/s00394-012-0334-4. Epub 2012 Mar 2.
blood
Amir Lerman, MD
Mayo Clinic
First Submitted
February 28, 2008
First Posted
March 7, 2008
Study Start
February 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2009
Actual (reported)A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848
Contact the study team to confirm eligibility.
Study Completion
December 2010
Actual (reported)Last Updated
August 12, 2011
Record last verified: 2011-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: